Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Beyer

Showing results (291-300 of 309) with videos related to

Pageof 31
Sort By:
Elife|August 24, 2016
Transient rapamycin treatment can increase lifespan and healthspan in middle-aged miceAlessandro Bitto, Takashi K Ito, Victor V Pineda, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 12, 2014
Diagnosis, therapy and control of diabetes mellitus in children and adolescentsA Neu, P Beyer, J Bürger-Büsing, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2012
Design, synthesis and structure-activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitorsMaria-Carmen Fernandez, Ana Escribano, Ana I Mateo, et al.
Toxicology and Applied Pharmacology|October 19, 2015
Susceptibility to quantum dot induced lung inflammation differs widely among the Collaborative Cross founder mouse strainsDavid K Scoville, Collin C White, Dianne Botta, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2024
Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activityYan Q Chen, Ye Yang, Eugene Y Zhen, et al.
The Journal of Biological Chemistry|November 5, 2002
Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesisGuoqing Cao, Yu Liang, Carol L Broderick, et al.
Cell Metabolism|October 24, 2006
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegenerationPatrick Weydt, Victor V Pineda, Anne E Torrence, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 2, 2026
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMTJan Styczynski, Gloria Tridello, Nina Knelange, et al.
British Journal of Anaesthesia|August 11, 2023
An anchor-tether 'hindered' HCN1 inhibitor is antihyperalgesic in a rat spared nerve injury neuropathic pain modelGareth R Tibbs, Rajendra Uprety, J David Warren, et al.
Clinical Immunology (Orlando, Fla.)|December 20, 2011
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruptionSabine D Allard, Brenda De Keersmaecker, Anna L de Goede, et al.
Pageof 31

Showing results (291-300 of 309) with videos related to

Sort By:
Pageof 31
Elife|August 24, 2016
Transient rapamycin treatment can increase lifespan and healthspan in middle-aged miceAlessandro Bitto, Takashi K Ito, Victor V Pineda, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 12, 2014
Diagnosis, therapy and control of diabetes mellitus in children and adolescentsA Neu, P Beyer, J Bürger-Büsing, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2012
Design, synthesis and structure-activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitorsMaria-Carmen Fernandez, Ana Escribano, Ana I Mateo, et al.
Toxicology and Applied Pharmacology|October 19, 2015
Susceptibility to quantum dot induced lung inflammation differs widely among the Collaborative Cross founder mouse strainsDavid K Scoville, Collin C White, Dianne Botta, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2024
Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activityYan Q Chen, Ye Yang, Eugene Y Zhen, et al.
The Journal of Biological Chemistry|November 5, 2002
Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesisGuoqing Cao, Yu Liang, Carol L Broderick, et al.
Cell Metabolism|October 24, 2006
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegenerationPatrick Weydt, Victor V Pineda, Anne E Torrence, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 2, 2026
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMTJan Styczynski, Gloria Tridello, Nina Knelange, et al.
British Journal of Anaesthesia|August 11, 2023
An anchor-tether 'hindered' HCN1 inhibitor is antihyperalgesic in a rat spared nerve injury neuropathic pain modelGareth R Tibbs, Rajendra Uprety, J David Warren, et al.
Clinical Immunology (Orlando, Fla.)|December 20, 2011
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruptionSabine D Allard, Brenda De Keersmaecker, Anna L de Goede, et al.
Pageof 31